Unexpected protein interaction suggests new ALS drug target
User rating: 4 / 5 after 2 vote(s)
Discovery of an unexpected protein-protein interaction has led University of Iowa scientists and colleagues to identify a drug that slows the progression of Amyotrophic Lateral Sclerosis (ALS) in mice and nearly doubles the animals' lifespan. The study is published Jan. 24 online in the Journal of Clinical Investigation.
Full story »
|

PhysOrg Forum
Video
Editorials
Free Magazines
Newsletter
Goto Archive
Suggest a story idea
Send feedback